303 related articles for article (PubMed ID: 25194927)
1. Management of pediatric and adult patients with medulloblastoma.
Martin AM; Raabe E; Eberhart C; Cohen KJ
Curr Treat Options Oncol; 2014 Dec; 15(4):581-94. PubMed ID: 25194927
[TBL] [Abstract][Full Text] [Related]
2. Updates on Management of Adult Medulloblastoma.
Majd N; Penas-Prado M
Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711
[TBL] [Abstract][Full Text] [Related]
3. Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossa?
Fukunaga-Johnson N; Lee JH; Sandler HM; Robertson P; McNeil E; Goldwein JW
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):143-6. PubMed ID: 9747831
[TBL] [Abstract][Full Text] [Related]
4. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
Khalil EM
J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474
[TBL] [Abstract][Full Text] [Related]
5. Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study.
Hill RM; Richardson S; Schwalbe EC; Hicks D; Lindsey JC; Crosier S; Rafiee G; Grabovska Y; Wharton SB; Jacques TS; Michalski A; Joshi A; Pizer B; Williamson D; Bailey S; Clifford SC
Lancet Child Adolesc Health; 2020 Dec; 4(12):865-874. PubMed ID: 33222802
[TBL] [Abstract][Full Text] [Related]
6. SEOM clinical guideline for management of adult medulloblastoma (2020).
Luque R; Benavides M; Del Barco S; Egaña L; García-Gómez J; Martínez-García M; Pérez-Segura P; Pineda E; Sepúlveda JM; Vieito M
Clin Transl Oncol; 2021 May; 23(5):940-947. PubMed ID: 33792841
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic outcome of medulloblastoma in 49 children.
Jaing TH; Hung IJ; Yang CP; Wang HS; Hung PC
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(4):279-85. PubMed ID: 7572172
[TBL] [Abstract][Full Text] [Related]
8. Molecular Classification Improves Therapeutic Options for Infants and Young Children With Medulloblastoma.
Bagchi A; Dhanda SK; Dunphy P; Sioson E; Robinson GW
J Natl Compr Canc Netw; 2023 Aug; 21(10):1097-1105. PubMed ID: 37643637
[TBL] [Abstract][Full Text] [Related]
9. Childhood medulloblastoma: progress and future challenges.
Packer RJ
Brain Dev; 1999 Mar; 21(2):75-81. PubMed ID: 10206522
[TBL] [Abstract][Full Text] [Related]
10. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
11. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
[TBL] [Abstract][Full Text] [Related]
12. Childhood medulloblastoma.
Massimino M; Biassoni V; Gandola L; Garrè ML; Gatta G; Giangaspero F; Poggi G; Rutkowski S
Crit Rev Oncol Hematol; 2016 Sep; 105():35-51. PubMed ID: 27375228
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma: clinical and biologic aspects.
Packer RJ; Cogen P; Vezina G; Rorke LB
Neuro Oncol; 1999 Jul; 1(3):232-50. PubMed ID: 11550316
[TBL] [Abstract][Full Text] [Related]
14. Understanding medulloblastoma.
Quinlan A; Rizzolo D
JAAPA; 2017 Oct; 30(10):30-36. PubMed ID: 28953021
[TBL] [Abstract][Full Text] [Related]
15. Medulloblastomas and central nervous system primitive neuroectodermal tumors.
McLean TW
Curr Treat Options Oncol; 2003 Dec; 4(6):499-508. PubMed ID: 14585230
[TBL] [Abstract][Full Text] [Related]
16. Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept.
Rieken S; Gaiser T; Mohr A; Welzel T; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
BMC Cancer; 2010 Aug; 10():450. PubMed ID: 20731859
[TBL] [Abstract][Full Text] [Related]
17. Management and outcomes of treating pediatric medulloblastoma: an eight years' experience in an Iranian pediatric center.
Mehrvar A; Tashvighi M; Hedayati Asl AA; Niktoreh-Mofrad N; Mehrvar N; Afsar N; Naderi A; Allebouyeh M; Qaddoumi I; Faranoush M
Childs Nerv Syst; 2018 Apr; 34(4):639-647. PubMed ID: 29214340
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and secondary malignancies in childhood medulloblastoma.
Stavrou T; Bromley CM; Nicholson HS; Byrne J; Packer RJ; Goldstein AM; Reaman GH
J Pediatr Hematol Oncol; 2001 Oct; 23(7):431-6. PubMed ID: 11878577
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.
Gupta T; Maitre M; Sastri GJ; Krishnatry R; Shirsat N; Epari S; Sahay A; Chinnaswamy G; Patil V; Shetty P; Moiyadi A
J Neurooncol; 2019 Sep; 144(2):283-291. PubMed ID: 31236820
[TBL] [Abstract][Full Text] [Related]
20. Medulloblastoma: what is the role of molecular genetics?
Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]